These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28666839)

  • 21. A review and analysis of the relationship between neuropsychological measures and DAT1 in ADHD.
    Rommelse NN; Altink ME; Arias-Vásquez A; Buschgens CJ; Fliers E; Faraone SV; Buitelaar JK; Sergeant JA; Franke B; Oosterlaan J
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1536-46. PubMed ID: 18729135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of dopamine gene variants, emotion dysregulation and ADHD in autism spectrum disorder.
    Gadow KD; Pinsonneault JK; Perlman G; Sadee W
    Res Dev Disabil; 2014 Jul; 35(7):1658-65. PubMed ID: 24780147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine transporter gene polymorphism moderates the effects of severe deprivation on ADHD symptoms: developmental continuities in gene-environment interplay.
    Stevens SE; Kumsta R; Kreppner JM; Brookes KJ; Rutter M; Sonuga-Barke EJ
    Am J Med Genet B Neuropsychiatr Genet; 2009 Sep; 150B(6):753-61. PubMed ID: 19655343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between the dopamine transporter gene (DAT1) and attention deficit hyperactivity disorder-related traits in healthy adults.
    Jeong SH; Choi KS; Lee KY; Kim EJ; Kim YS; Joo EJ
    Psychiatr Genet; 2015 Jun; 25(3):119-26. PubMed ID: 25915480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine risk and paternal ADHD symptomatology associated with ADHD symptoms in four and a half-year-old boys.
    Auerbach JG; Atzaba-Poria N; Berger A; Landau R; Arbelle S; Raz Y; Ebstein R
    Psychiatr Genet; 2010 Aug; 20(4):160-5. PubMed ID: 20421851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: a case-control association study in a Korean sample.
    Kim JW; Kim BN; Cho SC
    J Psychiatr Res; 2006 Dec; 40(8):730-7. PubMed ID: 16368111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Contribution of Maternal ADHD Symptomatology, Maternal DAT1, and Home Atmosphere to Child ADHD Symptomatology at 7 Years of Age.
    Auerbach JG; Zilberman-Hayun Y; Atzaba-Poria N; Berger A
    J Abnorm Child Psychol; 2017 Apr; 45(3):415-427. PubMed ID: 27873141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic heterogeneity in ADHD: DAT1 gene only affects probands without CD.
    Zhou K; Chen W; Buitelaar J; Banaschewski T; Oades RD; Franke B; Sonuga-Barke E; Ebstein R; Eisenberg J; Gill M; Manor I; Miranda A; Mulas F; Roeyers H; Rothenberger A; Sergeant J; Steinhausen HC; Lasky-Su J; Taylor E; Brookes KJ; Xu X; Neale BM; Rijsdijk F; Thompson M; Asherson P; Faraone SV
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1481-7. PubMed ID: 18553640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enlarged striatal volume in adults with ADHD carrying the 9-6 haplotype of the dopamine transporter gene DAT1.
    Onnink AM; Franke B; van Hulzen K; Zwiers MP; Mostert JC; Schene AH; Heslenfeld DJ; Oosterlaan J; Hoekstra PJ; Hartman CA; Vasquez AA; Kan CC; Buitelaar J; Hoogman M
    J Neural Transm (Vienna); 2016 Aug; 123(8):905-15. PubMed ID: 26935821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the dopamine transporter gene on striatal functional connectivity in youths with attention-deficit/hyperactivity disorder.
    Shang CY; Lin HY; Gau SS
    Psychol Med; 2021 Apr; 51(5):835-845. PubMed ID: 31907092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequence variation in the 3'-untranslated region of the dopamine transporter gene and attention-deficit hyperactivity disorder (ADHD).
    Feng Y; Wigg KG; Makkar R; Ickowicz A; Pathare T; Tannock R; Roberts W; Malone M; Kennedy JL; Schachar R; Barr CL
    Am J Med Genet B Neuropsychiatr Genet; 2005 Nov; 139B(1):1-6. PubMed ID: 16082693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: A preliminary study.
    Wiers CE; Lohoff FW; Lee J; Muench C; Freeman C; Zehra A; Marenco S; Lipska BK; Auluck PK; Feng N; Sun H; Goldman D; Swanson JM; Wang GJ; Volkow ND
    Eur J Neurosci; 2018 Aug; 48(3):1884-1895. PubMed ID: 30033547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variants of the SLC6A3 (DAT1) polymorphism affect performance monitoring-related cortical evoked potentials that are associated with ADHD.
    Althaus M; Groen Y; Wijers AA; Minderaa RB; Kema IP; Dijck JD; Hoekstra PJ
    Biol Psychol; 2010 Sep; 85(1):19-32. PubMed ID: 20450954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatial attentional bias as a marker of genetic risk, symptom severity, and stimulant response in ADHD.
    Bellgrove MA; Barry E; Johnson KA; Cox M; Dáibhis A; Daly M; Hawi Z; Lambert D; Fitzgerald M; McNicholas F; Robertson IH; Gill M; Kirley A
    Neuropsychopharmacology; 2008 Sep; 33(10):2536-45. PubMed ID: 18046306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD.
    Franke B; Vasquez AA; Johansson S; Hoogman M; Romanos J; Boreatti-Hümmer A; Heine M; Jacob CP; Lesch KP; Casas M; Ribasés M; Bosch R; Sánchez-Mora C; Gómez-Barros N; Fernàndez-Castillo N; Bayés M; Halmøy A; Halleland H; Landaas ET; Fasmer OB; Knappskog PM; Heister AJ; Kiemeney LA; Kooij JJ; Boonstra AM; Kan CC; Asherson P; Faraone SV; Buitelaar JK; Haavik J; Cormand B; Ramos-Quiroga JA; Reif A
    Neuropsychopharmacology; 2010 Feb; 35(3):656-64. PubMed ID: 19890261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double dissociation between lab measures of inattention and impulsivity and the dopamine transporter gene (DAT1) and dopamine D4 receptor gene (DRD4).
    Gizer IR; Waldman ID
    J Abnorm Psychol; 2012 Nov; 121(4):1011-23. PubMed ID: 22564179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential perinatal risk factors in children with attention-deficit/hyperactivity disorder by subtype.
    Park S; Cho SC; Kim JW; Shin MS; Yoo HJ; Oh SM; Han DH; Cheong JH; Kim BN
    Psychiatry Res; 2014 Nov; 219(3):609-16. PubMed ID: 24997783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine transporter gene variation modulates activation of striatum in youth with ADHD.
    Bédard AC; Schulz KP; Cook EH; Fan J; Clerkin SM; Ivanov I; Halperin JM; Newcorn JH
    Neuroimage; 2010 Nov; 53(3):935-42. PubMed ID: 20026227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between the dopamine transporter gene and the inattentive subtype of attention deficit hyperactivity disorder in Taiwan.
    Shang CY; Gau SS; Liu CM; Hwu HG
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):421-8. PubMed ID: 20800641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relations between multi-informant assessments of ADHD symptoms, DAT1, and DRD4.
    Gizer IR; Waldman ID; Abramowitz A; Barr CL; Feng Y; Wigg KG; Misener VL; Rowe DC
    J Abnorm Psychol; 2008 Nov; 117(4):869-80. PubMed ID: 19025233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.